Similar articles

• Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study.

  Schobess R, Kurnik K, Friedrichs F, Halimeh S, Krümpel A, Bidlingmaier C, Nowak-Göttl U. Schobess R, et al. Thromb Haemost. 2008 Jan;99(1):71-6. doi: 10.1160/TH07-06-0417. Thromb Haemost. 2008. PMID: 18217137
• Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A.

  Risebrough N, Oh P, Blanchette V, Curtin J, Hitzler J, Feldman BM. Risebrough N, et al. Haemophilia. 2008 Jul;14(4):743-52. doi: 10.1111/j.1365-2516.2008.01664.x. Epub 2008 Apr 16. Haemophilia. 2008. PMID: 18422610
• Evidence for the benefits of prophylaxis in the management of hemophilia A.

  Hoots WK, Nugent DJ. Hoots WK, et al. Thromb Haemost. 2006 Oct;96(4):433-40. doi: 10.1160/th06-02-0125. Thromb Haemost. 2006. PMID: 17003919 Review.
• Experience of secondary prophylaxis in 20 adolescent and adult Italian hemophiliacs.

  Tagliaferri A, Rivolta GF, Rossetti G, Pattacini C, Gandini G, Franchini M. Tagliaferri A, et al. Thromb Haemost. 2006 Oct;96(4):542-3. Thromb Haemost. 2006. PMID: 17003937 No abstract available.
• Prophylaxis in adults with haemophilia.

  Hay CR. Hay CR. Haemophilia. 2007 Sep;13 Suppl 2:10-5. doi: 10.1111/j.1365-2516.2007.01500.x. Haemophilia. 2007. PMID: 17685918 Review.